BHWM
IBB icon

Bar Harbor Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bar Harbor Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
16,535
+71
+0.4% +$12.2K 0.17% 111
2026
Q1 		$2.78M Buy
16,464
+1,303
+9% +$223K 0.16% 115
2025
Q4 		$2.56M Buy
15,161
+268
+2% +$43.5K 0.15% 120
2025
Q3 		$2.15M Sell
14,893
-675
-4% -$92.1K 0.13% 125
2025
Q2 		$1.97M Buy
15,568
+276
+2% +$33.9K 0.13% 123
2025
Q1 		$1.96M Sell
15,292
-372
-2% -$50.4K 0.13% 121
2024
Q4 		$2.07M Buy
15,664
+838
+6% +$118K 0.14% 121
2024
Q3 		$2.16M Sell
14,826
-491
-3% -$71K 0.14% 126
2024
Q2 		$2.1M Sell
15,317
-808
-5% -$108K 0.14% 122
2024
Q1 		$2.21M Buy
16,125
+1,515
+10% +$207K 0.15% 128
2023
Q4 		$1.98M Buy
14,610
+153
+1% +$18.7K 0.15% 120
2023
Q3 		$1.77M Sell
14,457
-492
-3% -$62.6K 0.14% 121
2023
Q2 		$1.9M Sell
14,949
-3,440
-19% -$447K 0.15% 120
2023
Q1 		$2.38M Buy
+18,389
New +$2.41M 0.19% 108
2021
Q3 		– Sell
-1,719
Closed -$281K – 250
2021
Q2 		$281K Sell
1,719
-459
-21% -$70.7K 0.03% 205
2021
Q1 		$328K Sell
2,178
-43
-2% -$6.83K 0.03% 193
2020
Q4 		$336K Buy
2,221
+35
+2% +$5K 0.03% 190
2020
Q3 		$296K Hold
2,186
– – 0.03% 192
2020
Q2 		$299K Hold
2,186
– – 0.03% 188
2020
Q1 		$236K Sell
2,186
-773
-26% -$89K 0.03% 213
2019
Q4 		$357K Sell
2,959
-1,591
-35% -$178K 0.04% 230
2019
Q3 		$453K Sell
4,550
-84
-2% -$8.79K 0.05% 212
2019
Q2 		$506K Sell
4,634
-282
-6% -$30K 0.06% 201
2019
Q1 		$550K Sell
4,916
-295
-6% -$32.4K 0.07% 184
2018
Q4 		$502K Sell
5,211
-2,901
-36% -$308K 0.07% 188
2018
Q3 		$989K Buy
8,112
+848
+12% +$99.9K 0.11% 147
2018
Q2 		$798K Buy
7,264
+774
+12% +$82.8K 0.1% 161
2018
Q1 		$693K Buy
+6,490
New +$719K 0.08% 170

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bar Harbor Wealth Management's IBB Position: Q2 2026 in Review

Bar Harbor Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 0.43% in Q2 2026, buying an estimated $12.2K and bringing the position to 16,535 shares worth $3.14M. The position accounts for 0.17% of the portfolio, ranked #111.

Bar Harbor Wealth Management first reported a position in IBB in Q1 2018 and has held it in 28 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Bar Harbor Wealth Management held 16,535 shares of iShares Biotechnology ETF worth $3.14M as of Q2 2026.
  • Bar Harbor Wealth Management bought 71 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.2K.
  • iShares Biotechnology ETF made up 0.17% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Bar Harbor Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 28 quarters since.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.